TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Stanford University
Stanford University
Eilean Therapeutics
University of Manitoba
Eilean Therapeutics
National Cancer Institute (NCI)
University of Miami
University of Turin, Italy
University of Arizona
Novartis
Shenzhen TargetRx Co., Ltd.
Assistance Publique - Hôpitaux de Paris
Novartis